Disparities exist in treatment, survival among black, white men with early stage breast cancer
the ONA take:
In this study, the researchers investigated the disparities between blacks and whites in receipt of treatment for early stage breast cancer in men age 18 to 64 years and men 65 years and older.
The study included 725 non-Hispanic black (black) and 5,247 non-Hispanic white (white) men with a diagnosis of early stage breast cancer from 2004 to 2011 in the National Cancer Data Base.
Receipt of treatment was found to be remarkably similar between blacks and whites in both age groups. In both races, fewer older men received chemotherapy compared with younger men.
Risk of death, however, was higher for the younger black men than the younger white men, but the difference was significantly less after adjustments for covariates. That risk was not significant and not affected by covariates in the groups of older men.
Higher risk of death in black men vs white men is limited to men age 18 to 64 years and became nonsignificant after adjustments for insurance and income.
The researchers conclude that improving access to care is an important factor in reducing the disparities in male breast cancer mortality.
Researchers investigated the disparities between blacks and whites in receipt of treatment for early stage breast cancer.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|